Growth Metrics

Cryoport (CYRX) Liabilities and Shareholders Equity (2016 - 2026)

Cryoport has reported Liabilities and Shareholders Equity over the past 16 years, most recently at $763.6 million for Q1 2026.

  • Quarterly Liabilities and Shareholders Equity rose 9.11% to $763.6 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $3.1 billion through Mar 2026, up 4.04% year-over-year, with the annual reading at $765.0 million for FY2025, 8.74% up from the prior year.
  • Liabilities and Shareholders Equity was $763.6 million for Q1 2026 at Cryoport, roughly flat from $765.0 million in the prior quarter.
  • Over five years, Liabilities and Shareholders Equity peaked at $1.1 billion in Q1 2022 and troughed at $699.8 million in Q1 2025.
  • The 5-year median for Liabilities and Shareholders Equity is $942.8 million (2024), against an average of $895.0 million.
  • Year-over-year, Liabilities and Shareholders Equity skyrocketed 31.92% in 2022 and then decreased 29.87% in 2024.
  • A 5-year view of Liabilities and Shareholders Equity shows it stood at $1.0 billion in 2022, then fell by 7.8% to $957.7 million in 2023, then fell by 26.55% to $703.5 million in 2024, then rose by 8.74% to $765.0 million in 2025, then dropped by 0.18% to $763.6 million in 2026.
  • Per Business Quant, the three most recent readings for CYRX's Liabilities and Shareholders Equity are $763.6 million (Q1 2026), $765.0 million (Q4 2025), and $774.3 million (Q3 2025).